Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Neoplasms 1Lymphoma 1Leukemia 1Leiomyoma 1Hypertension 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nitroprusside × Clear all
NCT03953326 2026-02-27

HeartPhone Cancer Survivors Trial 2019

Penn State University

Phase 1/2 Terminated
2 enrolled 6 charts
BreastLymphoidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Lymphoma

NCT02123069 2018-03-02

Vascular Function and Uterine Fibroids

Mayo Clinic

Completed
28 enrolled

Leiomyoma

NCT01125943 2013-01-10

Bevacizumab and Endothelium Dependent Vasodilation

Radboud University Medical Center

Phase NA Completed
24 enrolled

Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡